Choloepus didactylus isolate mChoDid1 chromosome 20, mChoDid1.pri, whole genome shotgun sequence.
Choloepus didactylus (southern two-toed sloth)
Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia; Eutheria; Xenarthra; Pilosa; Folivora; Megalonychidae; Choloepus.
REFSEQ INFORMATION: The reference sequence is identical to\nCM026709.1.\nAssembly name: mChoDid1.pri\nThe genomic sequence for this RefSeq record is from the\nwhole-genome assembly released by the Vertebrate Genomes Project on\n2020/11/03. The original whole-genome shotgun project has the\naccession JADCNF000000000.1.\n\n##Genome-Assembly-Data-START##\nAssembly Provider :: Vertebrate Genomes Project\nAssembly Date :: 14-SEP-2020\nAssembly Method :: FALCON v. falcon-2018.31.08-03.06;\n FALCON-Unzip v. 6.0.0.47841; purge_dups\n github v.\n ca23030ccf4254dfd2d3a5ea90d0eed41c24f88b;\n Scaff10x v. 4.1.0; Bionano Solve v.\n 3.2.1_04122018; Salsa2 HiC v. 2.2; Polish\n pbgcpp v. 1.9.0; Longranger Align v.\n 2.2.2; freebayes v. 1.3.1; gEVAL manual\n curation v. 2020-09-14; VGP assembly\n pipeline v. 1.6\nAssembly Name :: mChoDid1.pri\nDiploid :: Principal pseudohaplotype\nGenome Representation :: Full\nExpected Final Version :: No\nGenome Coverage :: 56.84x\nSequencing Technology :: PacBio Sequel I CLR; Illumina NovaSeq;\n Arima Genomics Hi-C; Bionano Genomics DLS\n##Genome-Assembly-Data-END##\n\n##Genome-Annotation-Data-START##\nAnnotation Provider :: NCBI\nAnnotation Status :: Full annotation\nAnnotation Name :: Choloepus didactylus Annotation\n Release 100\nAnnotation Version :: 100\nAnnotation Pipeline :: NCBI eukaryotic genome annotation\n pipeline\nAnnotation Software Version :: 8.5\nAnnotation Method :: Best-placed RefSeq; Gnomon\nFeatures Annotated :: Gene; mRNA; CDS; ncRNA\n##Genome-Annotation-Data-END##
Derived by automated computational analysis using gene prediction method: Gnomon.
solute carrier family 66 member 3, transcript variant X6
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 10 samples with support for all annotated introns
solute carrier family 66 member 3, transcript variant X5
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 8 samples with support for all annotated introns
solute carrier family 66 member 3, transcript variant X4
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 3 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 12 samples with support for all annotated introns
solute carrier family 66 member 3, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 10 samples with support for all annotated introns
solute carrier family 66 member 3, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 9 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 12 samples with support for all annotated introns
solute carrier family 66 member 3 isoform X1
solute carrier family 66 member 3 isoform X2
solute carrier family 66 member 3 isoform X4
solute carrier family 66 member 3 isoform X5
solute carrier family 66 member 3, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 12 samples with support for all annotated introns
solute carrier family 66 member 3 isoform X3
Rho associated coiled-coil containing protein kinase 2, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 3 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 6 samples with support for all annotated introns
Rho associated coiled-coil containing protein kinase 2, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 23 Proteins, and 99% coverage of the annotated genomic feature by RNAseq alignments, including 10 samples with support for all annotated introns
Rho associated coiled-coil containing protein kinase 2, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 3 Proteins, and 99% coverage of the annotated genomic feature by RNAseq alignments, including 6 samples with support for all annotated introns
Rho associated coiled-coil containing protein kinase 2, transcript variant X5
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 3 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 4 samples with support for all annotated introns
rho-associated protein kinase 2 isoform X1
Rho associated coiled-coil containing protein kinase 2, transcript variant X4
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 3 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 2 samples with support for all annotated introns
rho-associated protein kinase 2 isoform X2
Derived by automated computational analysis using gene prediction method: cmsearch.
COORDINATES: nucleotide motif:Rfam:12.0:RF00003
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 22 Proteins, and 38% coverage of the annotated genomic feature by RNAseq alignments
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 86% coverage of the annotated genomic feature by RNAseq alignments
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 4 Proteins
E2F transcription factor 6, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 25 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 12 samples with support for all annotated introns
E2F transcription factor 6, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 Proteins, and 89% coverage of the annotated genomic feature by RNAseq alignments
growth regulating estrogen receptor binding 1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 8 Proteins, and 90% coverage of the annotated genomic feature by RNAseq alignments
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein
guanine nucleotide exchange factor subunit RIC1-like
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 2 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 23 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 4 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 14 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 4 samples with support for all annotated introns
phosphatidate phosphatase LPIN1 isoform X1
phosphatidate phosphatase LPIN1 isoform X3
phosphatidate phosphatase LPIN1 isoform X2
phosphatidate phosphatase LPIN1 isoform X4
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 15 Proteins
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 4 samples with support for all annotated introns
tribbles pseudokinase 2, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 22 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 6 samples with support for all annotated introns
tribbles pseudokinase 2, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 31 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 10 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 5 Proteins
uncharacterized LOC119516876, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 2 samples with support for all annotated introns
uncharacterized LOC119516876, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments
uncharacterized LOC119516876, transcript variant X2
NBAS subunit of NRZ tethering complex, transcript variant X1
neuroblastoma-amplified sequence isoform X1
NBAS subunit of NRZ tethering complex, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 3 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 10 samples with support for all annotated introns
neuroblastoma-amplified sequence isoform X2
axonemal dynein light intermediate polypeptide 1-like
The sequence of the model RefSeq transcript was modified relative to this genomic sequence to represent the inferred CDS: deleted 2 bases in 1 codon; Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 52% coverage of the annotated genomic feature by RNAseq alignments
The sequence of the model RefSeq protein was modified relative to this genomic sequence to represent the inferred CDS: deleted 2 bases in 1 codon; substituted 1 base at 1 genomic stop codon; Derived by automated computational analysis using gene prediction method: Gnomon.
LOW QUALITY PROTEIN: axonemal dynein light intermediate polypeptide 1-like
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 8 Proteins, and 31% coverage of the annotated genomic feature by RNAseq alignments
Derived by automated computational analysis using gene prediction method: tRNAscan-SE.
transfer RNA isoleucine (anticodon GAU); Derived by automated computational analysis using gene prediction method: tRNAscan-SE.
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 10 Proteins, and 55% coverage of the annotated genomic feature by RNAseq alignments
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 16 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 12 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 8 Proteins
MYCN proto-oncogene, bHLH transcription factor
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 9 Proteins, and 99% coverage of the annotated genomic feature by RNAseq alignments, including 2 samples with support for all annotated introns
transfer RNA lysine (anticodon CUU); Derived by automated computational analysis using gene prediction method: tRNAscan-SE.
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 16 Proteins
CYFIP related Rac1 interactor A, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 19 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 6 samples with support for all annotated introns
CYFIP related Rac1 interactor A, transcript variant X5
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 19 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 8 samples with support for all annotated introns
CYFIP related Rac1 interactor A, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 19 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 10 samples with support for all annotated introns
CYFIP related Rac1 interactor A, transcript variant X4
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 19 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 2 samples with support for all annotated introns
CYFIP related Rac1 interactor A, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 19 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 4 samples with support for all annotated introns
CYFIP related Rac1 interactor A, transcript variant X6
uncharacterized LOC119516627, transcript variant X2
uncharacterized LOC119516627, transcript variant X1
overexpressed in colon carcinoma 1 protein-like
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 3 Proteins
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 41 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 8 samples with support for all annotated introns
structural maintenance of chromosomes 6, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 14 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 12 samples with support for all annotated introns
structural maintenance of chromosomes 6, transcript variant X2
structural maintenance of chromosomes protein 6 isoform X1
structural maintenance of chromosomes protein 6 isoform X2
serine/arginine repetitive matrix protein 1-like
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 75% coverage of the annotated genomic feature by RNAseq alignments
GEN1 Holliday junction 5' flap endonuclease, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 9 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 6 samples with support for all annotated introns
GEN1 Holliday junction 5' flap endonuclease, transcript variant X2
flap endonuclease GEN homolog 1 isoform X1
GEN1 Holliday junction 5' flap endonuclease, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 6 samples with support for all annotated introns
flap endonuclease GEN homolog 1 isoform X2
The sequence of the model RefSeq transcript was modified relative to this genomic sequence to represent the inferred CDS: inserted 1 base in 1 codon; Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 Proteins, and 29% coverage of the annotated genomic feature by RNAseq alignments
The sequence of the model RefSeq protein was modified relative to this genomic sequence to represent the inferred CDS: inserted 1 base in 1 codon; Derived by automated computational analysis using gene prediction method: Gnomon.
LOW QUALITY PROTEIN: uncharacterized protein LOC119516399
uncharacterized LOC119516613, transcript variant X2
uncharacterized LOC119516613, transcript variant X1
potassium voltage-gated channel modifier subfamily S member 3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 17 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments
potassium voltage-gated channel subfamily S member 3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 11 Proteins
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 17 Proteins
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 9 Proteins
odd-skipped related transcription factor 1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 18 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 2 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 11 Proteins, and 24% coverage of the annotated genomic feature by RNAseq alignments
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 5 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 12 samples with support for all annotated introns
WD repeat domain 35, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 6 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 4 samples with support for all annotated introns
WD repeat domain 35, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 5 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 2 samples with support for all annotated introns
WD repeat-containing protein 35 isoform X2
WD repeat-containing protein 35 isoform X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 Proteins, and 98% coverage of the annotated genomic feature by RNAseq alignments, including 8 samples with support for all annotated introns
lysosomal-associated transmembrane protein 4A
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 17 Proteins, and 95% coverage of the annotated genomic feature by RNAseq alignments
uncharacterized LOC119516922, transcript variant X2
uncharacterized LOC119516922, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 13 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 12 samples with support for all annotated introns
pumilio RNA binding family member 2, transcript variant X5
pumilio RNA binding family member 2, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 3 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 8 samples with support for all annotated introns
pumilio RNA binding family member 2, transcript variant X7
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 6 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 12 samples with support for all annotated introns
pumilio RNA binding family member 2, transcript variant X6
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 12 samples with support for all annotated introns
pumilio RNA binding family member 2, transcript variant X4
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 7 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 12 samples with support for all annotated introns
pumilio RNA binding family member 2, transcript variant X1
pumilio RNA binding family member 2, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 5 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 6 samples with support for all annotated introns
pumilio RNA binding family member 2, transcript variant X8
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 30 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments
uncharacterized LOC119516904, transcript variant X1
uncharacterized LOC119516904, transcript variant X3
uncharacterized LOC119516904, transcript variant X2
uncharacterized LOC119516904, transcript variant X4
HCLS1 binding protein 3, transcript variant X2
HCLS1 binding protein 3, transcript variant X1
growth differentiation factor 7, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 10 Proteins, and 87% coverage of the annotated genomic feature by RNAseq alignments, including 2 samples with support for all annotated introns
growth differentiation factor 7, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 10 Proteins, and 86% coverage of the annotated genomic feature by RNAseq alignments, including 2 samples with support for all annotated introns
growth differentiation factor 7, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 10 Proteins, and 85% coverage of the annotated genomic feature by RNAseq alignments, including 2 samples with support for all annotated introns
growth differentiation factor 7, transcript variant X4
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 10 Proteins, and 63% coverage of the annotated genomic feature by RNAseq alignments, including 2 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 26 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 4 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 Proteins
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 5 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments
uncharacterized LOC119516664, transcript variant X4
uncharacterized LOC119516664, transcript variant X2
uncharacterized LOC119516664, transcript variant X3
uncharacterized LOC119516664, transcript variant X1
COORDINATES: nucleotide motif:Rfam:12.0:RF00026
kelch like family member 29, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 7 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 4 samples with support for all annotated introns
kelch like family member 29, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 7 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 2 samples with support for all annotated introns
kelch like family member 29, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 25 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments
uncharacterized LOC119516314, transcript variant X2
uncharacterized LOC119516314, transcript variant X1
ATPase family AAA domain containing 2B, transcript variant X6
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 10 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 4 samples with support for all annotated introns
ATPase family AAA domain containing 2B, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 4 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 4 samples with support for all annotated introns
ATPase family AAA domain containing 2B, transcript variant X4
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 4 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 2 samples with support for all annotated introns
ATPase family AAA domain containing 2B, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 4 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 6 samples with support for all annotated introns
ATPase family AAA domain containing 2B, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 13 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 6 samples with support for all annotated introns
ATPase family AAA domain containing 2B, transcript variant X8
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 4 Proteins, and 99% coverage of the annotated genomic feature by RNAseq alignments
ATPase family AAA domain containing 2B, transcript variant X5
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 9 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 2 samples with support for all annotated introns
ATPase family AAA domain containing 2B, transcript variant X7
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 8 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 4 samples with support for all annotated introns
ATPase family AAA domain-containing protein 2B isoform X3
ATPase family AAA domain-containing protein 2B isoform X4
ATPase family AAA domain-containing protein 2B isoform X2
ATPase family AAA domain-containing protein 2B isoform X1
ATPase family AAA domain-containing protein 2B isoform X7
ATPase family AAA domain-containing protein 2B isoform X5
ATPase family AAA domain-containing protein 2B isoform X6
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 35 Proteins
UBX domain protein 2A, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 7 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 10 samples with support for all annotated introns
UBX domain protein 2A, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 7 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 6 samples with support for all annotated introns
UBX domain-containing protein 2A isoform X1
UBX domain-containing protein 2A isoform X2
major facilitator superfamily domain containing 2B, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 4 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 8 samples with support for all annotated introns
major facilitator superfamily domain containing 2B, transcript variant X2
major facilitator superfamily domain containing 2B, transcript variant X7
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 6 samples with support for all annotated introns
major facilitator superfamily domain containing 2B, transcript variant X3
major facilitator superfamily domain containing 2B, transcript variant X5
major facilitator superfamily domain containing 2B, transcript variant X6
major facilitator superfamily domain containing 2B, transcript variant X4
major facilitator superfamily domain-containing protein 2B isoform X1
major facilitator superfamily domain-containing protein 2B isoform X2
major facilitator superfamily domain-containing protein 2B isoform X6
major facilitator superfamily domain-containing protein 2B isoform X4
major facilitator superfamily domain-containing protein 2B isoform X5
major facilitator superfamily domain-containing protein 2B isoform X3
WD repeat and coiled coil containing, transcript variant X3
WD repeat and coiled coil containing, transcript variant X4
WD repeat and coiled-coil-containing protein isoform X2
WD repeat and coiled coil containing, transcript variant X1
WD repeat and coiled coil containing, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 2 samples with support for all annotated introns
WD repeat and coiled-coil-containing protein isoform X1
WD repeat and coiled coil containing, transcript variant X5
WD repeat and coiled-coil-containing protein isoform X3
WD repeat and coiled coil containing, transcript variant X6
FKBP prolyl isomerase 1B, transcript variant X5
FKBP prolyl isomerase 1B, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 20 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 12 samples with support for all annotated introns
FKBP prolyl isomerase 1B, transcript variant X3
FKBP prolyl isomerase 1B, transcript variant X4
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 10 samples with support for all annotated introns
peptidyl-prolyl cis-trans isomerase FKBP1B isoform X1
peptidyl-prolyl cis-trans isomerase FKBP1B isoform X3
peptidyl-prolyl cis-trans isomerase FKBP1B isoform X4
FKBP prolyl isomerase 1B, transcript variant X2
FKBP prolyl isomerase 1B, transcript variant X6
peptidyl-prolyl cis-trans isomerase FKBP1B isoform X2
peptidyl-prolyl cis-trans isomerase FKBP1B isoform X5
splicing factor 3b subunit 6, transcript variant X1
splicing factor 3b subunit 6, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 11 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 12 samples with support for all annotated introns
tumor protein p53 inducible protein 3, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 7 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 8 samples with support for all annotated introns
tumor protein p53 inducible protein 3, transcript variant X3
tumor protein p53 inducible protein 3, transcript variant X4
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 95% coverage of the annotated genomic feature by RNAseq alignments
tumor protein p53 inducible protein 3, transcript variant X1
profilin family member 4, transcript variant X8
profilin family member 4, transcript variant X7
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 6 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 8 samples with support for all annotated introns
profilin family member 4, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 6 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 10 samples with support for all annotated introns
profilin family member 4, transcript variant X4
profilin family member 4, transcript variant X6
profilin family member 4, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 6 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 6 samples with support for all annotated introns
profilin family member 4, transcript variant X1
profilin family member 4, transcript variant X5
family with sequence similarity 228 member B
The sequence of the model RefSeq transcript was modified relative to this genomic sequence to represent the inferred CDS: deleted 1 base in 1 codon; Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 8 Proteins, and 90% coverage of the annotated genomic feature by RNAseq alignments, including 6 samples with support for all annotated introns
The sequence of the model RefSeq protein was modified relative to this genomic sequence to represent the inferred CDS: deleted 1 base in 1 codon; Derived by automated computational analysis using gene prediction method: Gnomon.
family with sequence similarity 228 member A
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 90% coverage of the annotated genomic feature by RNAseq alignments
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 13 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 2 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 48 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 10 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 10 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 2 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 8 Proteins, and 99% coverage of the annotated genomic feature by RNAseq alignments
nuclear receptor coactivator 1, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 8 Proteins, and 99% coverage of the annotated genomic feature by RNAseq alignments, including 2 samples with support for all annotated introns
nuclear receptor coactivator 1, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 8 Proteins, and 99% coverage of the annotated genomic feature by RNAseq alignments, including 10 samples with support for all annotated introns
nuclear receptor coactivator 1, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 8 Proteins, and 98% coverage of the annotated genomic feature by RNAseq alignments, including 12 samples with support for all annotated introns
nuclear receptor coactivator 1, transcript variant X4
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 3 Proteins, and 97% coverage of the annotated genomic feature by RNAseq alignments, including 12 samples with support for all annotated introns
nuclear receptor coactivator 1 isoform X1
nuclear receptor coactivator 1 isoform X2
nuclear receptor coactivator 1, transcript variant X5
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 8 Proteins, and 97% coverage of the annotated genomic feature by RNAseq alignments, including 12 samples with support for all annotated introns
nuclear receptor coactivator 1, transcript variant X6
nuclear receptor coactivator 1 isoform X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 11 Proteins, and 83% coverage of the annotated genomic feature by RNAseq alignments
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 62 Proteins, and 84% coverage of the annotated genomic feature by RNAseq alignments
centromere protein O, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 5 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 4 samples with support for all annotated introns
centromere protein O, transcript variant X3
centromere protein O, transcript variant X2
centromere protein O, transcript variant X5
centromere protein O, transcript variant X4
centromere protein O, transcript variant X6
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 8 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 8 samples with support for all annotated introns
adenylate cyclase 3, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 23 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 8 samples with support for all annotated introns
adenylate cyclase 3, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 23 Proteins, and 99% coverage of the annotated genomic feature by RNAseq alignments, including 8 samples with support for all annotated introns
adenylate cyclase 3, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 8 samples with support for all annotated introns
DnaJ heat shock protein family (Hsp40) member C27
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 12 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 8 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 12 Proteins, and 97% coverage of the annotated genomic feature by RNAseq alignments
proopiomelanocortin, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 15 Proteins, and 99% coverage of the annotated genomic feature by RNAseq alignments, including 2 samples with support for all annotated introns
proopiomelanocortin, transcript variant X1
DNA methyltransferase 3 alpha, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 30 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 6 samples with support for all annotated introns
DNA methyltransferase 3 alpha, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 34 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 10 samples with support for all annotated introns
DNA methyltransferase 3 alpha, transcript variant X9
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 21 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 8 samples with support for all annotated introns
DNA methyltransferase 3 alpha, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 21 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 6 samples with support for all annotated introns
DNA methyltransferase 3 alpha, transcript variant X5
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 21 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 10 samples with support for all annotated introns
DNA methyltransferase 3 alpha, transcript variant X4
DNA methyltransferase 3 alpha, transcript variant X6
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 21 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 4 samples with support for all annotated introns
DNA methyltransferase 3 alpha, transcript variant X7
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 20 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 6 samples with support for all annotated introns
DNA methyltransferase 3 alpha, transcript variant X8
DNA (cytosine-5)-methyltransferase 3A isoform X1
DNA (cytosine-5)-methyltransferase 3A isoform X2
DNA (cytosine-5)-methyltransferase 3A isoform X3
DNA (cytosine-5)-methyltransferase 3A isoform X4
DNA (cytosine-5)-methyltransferase 3A isoform X5
DNA (cytosine-5)-methyltransferase 3A isoform X6
dystrobrevin beta, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 15 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 2 samples with support for all annotated introns
dystrobrevin beta, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 15 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 8 samples with support for all annotated introns
dystrobrevin beta, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 15 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 6 samples with support for all annotated introns
dystrobrevin beta, transcript variant X4
dystrobrevin beta, transcript variant X12
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 5 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 8 samples with support for all annotated introns
dystrobrevin beta, transcript variant X9
dystrobrevin beta, transcript variant X11
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 9 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 8 samples with support for all annotated introns
dystrobrevin beta, transcript variant X7
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 11 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 8 samples with support for all annotated introns
dystrobrevin beta, transcript variant X5
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 20 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 10 samples with support for all annotated introns
dystrobrevin beta, transcript variant X10
dystrobrevin beta, transcript variant X8
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 10 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 8 samples with support for all annotated introns
dystrobrevin beta, transcript variant X6
dystrobrevin beta, transcript variant X13
dystrobrevin beta, transcript variant X14
dystrobrevin beta, transcript variant X15
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 5 Proteins, and 39% coverage of the annotated genomic feature by RNAseq alignments
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 6 Proteins, and 42% coverage of the annotated genomic feature by RNAseq alignments
ASXL transcriptional regulator 2, transcript variant X3
ASXL transcriptional regulator 2, transcript variant X2
ASXL transcriptional regulator 2, transcript variant X1
ASXL transcriptional regulator 2, transcript variant X4
ASXL transcriptional regulator 2, transcript variant X5
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 6 samples with support for all annotated introns
putative Polycomb group protein ASXL2 isoform X2
putative Polycomb group protein ASXL2 isoform X1
putative Polycomb group protein ASXL2 isoform X3
putative Polycomb group protein ASXL2 isoform X4
ribose-phosphate pyrophosphokinase 1-like
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 36 Proteins, and 90% coverage of the annotated genomic feature by RNAseq alignments
kinesin family member 3C, transcript variant X1
kinesin family member 3C, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 7 Proteins, and 99% coverage of the annotated genomic feature by RNAseq alignments
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 58 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 12 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 9 Proteins, and 59% coverage of the annotated genomic feature by RNAseq alignments
GRB2 associated regulator of MAPK1 subtype 2
The sequence of the model RefSeq transcript was modified relative to this genomic sequence to represent the inferred CDS: inserted 1 base in 1 codon; Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 7 Proteins, and 99% coverage of the annotated genomic feature by RNAseq alignments, including 4 samples with support for all annotated introns
LOW QUALITY PROTEIN: GRB2-associated and regulator of MAPK protein 2
hydroxyacyl-CoA dehydrogenase trifunctional multienzyme complex subunit alpha
trifunctional enzyme subunit alpha, mitochondrial
hydroxyacyl-CoA dehydrogenase trifunctional multienzyme complex subunit beta
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 12 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 12 samples with support for all annotated introns
trifunctional enzyme subunit beta, mitochondrial
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 20 Proteins, and 30% coverage of the annotated genomic feature by RNAseq alignments
adhesion G protein-coupled receptor F3, transcript variant X4
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 Proteins, and 99% coverage of the annotated genomic feature by RNAseq alignments, including 2 samples with support for all annotated introns
adhesion G protein-coupled receptor F3, transcript variant X5
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 99% coverage of the annotated genomic feature by RNAseq alignments, including 2 samples with support for all annotated introns
adhesion G protein-coupled receptor F3, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 4 Proteins, and 99% coverage of the annotated genomic feature by RNAseq alignments, including 2 samples with support for all annotated introns
adhesion G protein-coupled receptor F3, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 4 Proteins, and 99% coverage of the annotated genomic feature by RNAseq alignments, including 4 samples with support for all annotated introns
adhesion G-protein coupled receptor F3 isoform X3
adhesion G-protein coupled receptor F3 isoform X4
adhesion G-protein coupled receptor F3 isoform X5
adhesion G-protein coupled receptor F3 isoform X1
adhesion G protein-coupled receptor F3, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 6 Proteins, and 99% coverage of the annotated genomic feature by RNAseq alignments, including 4 samples with support for all annotated introns
adhesion G-protein coupled receptor F3 isoform X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 14 Proteins, and 25% coverage of the annotated genomic feature by RNAseq alignments
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 7 Proteins, and 73% coverage of the annotated genomic feature by RNAseq alignments
The sequence of the model RefSeq transcript was modified relative to this genomic sequence to represent the inferred CDS: deleted 1 base in 1 codon; Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 6 Proteins, and 96% coverage of the annotated genomic feature by RNAseq alignments
LOW QUALITY PROTEIN: dynein regulatory complex protein 1
oral-facial-digital syndrome 1 protein-like, transcript variant X2
oral-facial-digital syndrome 1 protein-like, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 10 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 12 samples with support for all annotated introns
oral-facial-digital syndrome 1 protein-like
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 21 Proteins
The sequence of the model RefSeq transcript was modified relative to this genomic sequence to represent the inferred CDS: deleted 1 base in 1 codon; Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 6 Proteins, and 80% coverage of the annotated genomic feature by RNAseq alignments
family with sequence similarity 166 member C
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 5 Proteins, and 96% coverage of the annotated genomic feature by RNAseq alignments
potassium two pore domain channel subfamily K member 3
solute carrier family 35 member F6, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 11 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 10 samples with support for all annotated introns
solute carrier family 35 member F6 isoform X2
solute carrier family 35 member F6, transcript variant X1
solute carrier family 35 member F6 isoform X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 9 Proteins, and 98% coverage of the annotated genomic feature by RNAseq alignments
dihydropyrimidinase like 5, transcript variant X1
dihydropyrimidinase like 5, transcript variant X2
microtubule associated protein RP/EB family member 3, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 26 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 2 samples with support for all annotated introns
microtubule-associated protein RP/EB family member 3 isoform X1
microtubule associated protein RP/EB family member 3, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 32 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 12 samples with support for all annotated introns
microtubule-associated protein RP/EB family member 3 isoform X2
transmembrane protein 214, transcript variant X1
transmembrane protein 214, transcript variant X2
transfer RNA tyrosine (anticodon GUA); Derived by automated computational analysis using gene prediction method: tRNAscan-SE.
transfer RNA alanine (anticodon AGC); Derived by automated computational analysis using gene prediction method: tRNAscan-SE.
ATP/GTP binding protein like 5, transcript variant X1
ATP/GTP binding protein like 5, transcript variant X4
ATP/GTP binding protein like 5, transcript variant X2
ATP/GTP binding protein like 5, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 8 Proteins, and 99% coverage of the annotated genomic feature by RNAseq alignments, including 12 samples with support for all annotated introns
cytosolic carboxypeptidase-like protein 5 isoform X1
cytosolic carboxypeptidase-like protein 5 isoform X2
ATP/GTP binding protein like 5, transcript variant X5
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 9 Proteins, and 99% coverage of the annotated genomic feature by RNAseq alignments, including 12 samples with support for all annotated introns
ATP/GTP binding protein like 5, transcript variant X6
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 3 Proteins, and 99% coverage of the annotated genomic feature by RNAseq alignments, including 4 samples with support for all annotated introns
cytosolic carboxypeptidase-like protein 5 isoform X4
cytosolic carboxypeptidase-like protein 5 isoform X3
oligosaccharyltransferase complex subunit 4, non-catalytic
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 8 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 12 samples with support for all annotated introns
dolichyl-diphosphooligosaccharide--protein glycosyltransferase subunit 4
cell growth regulator with EF-hand domain 1, transcript variant X2
cell growth regulator with EF-hand domain 1, transcript variant X1
cell growth regulator with EF-hand domain 1, transcript variant X6
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 10 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 10 samples with support for all annotated introns
cell growth regulator with EF-hand domain 1, transcript variant X5
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 10 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 6 samples with support for all annotated introns
cell growth regulator with EF-hand domain 1, transcript variant X4
cell growth regulator with EF-hand domain 1, transcript variant X3
cell growth regulator with EF hand domain protein 1 isoform X2
cell growth regulator with EF hand domain protein 1 isoform X1
cell growth regulator with EF hand domain protein 1 isoform X3
abhydrolase domain containing 1, transcript variant X2
abhydrolase domain containing 1, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 8 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 10 samples with support for all annotated introns
abhydrolase domain containing 1, transcript variant X3
prolactin regulatory element-binding protein
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 6 Proteins, and 59% coverage of the annotated genomic feature by RNAseq alignments
non-histone chromosomal protein HMG-17-like
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 5 Proteins, and 8% coverage of the annotated genomic feature by RNAseq alignments
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 35 Proteins, and 75% coverage of the annotated genomic feature by RNAseq alignments
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 3 Proteins, and 77% coverage of the annotated genomic feature by RNAseq alignments
solute carrier family 5 member 6, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 17 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 6 samples with support for all annotated introns
solute carrier family 5 member 6, transcript variant X6
solute carrier family 5 member 6, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 17 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 10 samples with support for all annotated introns
solute carrier family 5 member 6, transcript variant X5
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 17 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 8 samples with support for all annotated introns
solute carrier family 5 member 6, transcript variant X4
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 17 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 4 samples with support for all annotated introns
solute carrier family 5 member 6, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 17 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 12 samples with support for all annotated introns
sodium-dependent multivitamin transporter
all-trans retinoic acid induced differentiation factor
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 15 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 12 samples with support for all annotated introns
all-trans retinoic acid-induced differentiation factor
carbamoyl-phosphate synthetase 2, aspartate transcarbamylase, and dihydroorotase, transcript variant X3
carbamoyl-phosphate synthetase 2, aspartate transcarbamylase, and dihydroorotase, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 18 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 10 samples with support for all annotated introns
carbamoyl-phosphate synthetase 2, aspartate transcarbamylase, and dihydroorotase, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 24 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 12 samples with support for all annotated introns
DnaJ heat shock protein family (Hsp40) member C5 gamma
The sequence of the model RefSeq transcript was modified relative to this genomic sequence to represent the inferred CDS: deleted 1 base in 1 codon; Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 4 Proteins, and 97% coverage of the annotated genomic feature by RNAseq alignments, including 2 samples with support for all annotated introns
LOW QUALITY PROTEIN: dnaJ homolog subfamily C member 5G
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 34 Proteins, and 97% coverage of the annotated genomic feature by RNAseq alignments
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 6 Proteins, and 20% coverage of the annotated genomic feature by RNAseq alignments
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 7 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments
mitochondrial inner membrane protein MPV17, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 8 samples with support for all annotated introns
mitochondrial inner membrane protein MPV17, transcript variant X6
mitochondrial inner membrane protein MPV17, transcript variant X1
mitochondrial inner membrane protein MPV17, transcript variant X3
mitochondrial inner membrane protein MPV17, transcript variant X7
mitochondrial inner membrane protein MPV17, transcript variant X4
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 4 samples with support for all annotated introns
mitochondrial inner membrane protein MPV17, transcript variant X5
general transcription factor IIIC subunit 2, transcript variant X4
general transcription factor IIIC subunit 2, transcript variant X2
general transcription factor IIIC subunit 2, transcript variant X1
general transcription factor IIIC subunit 2, transcript variant X3
general transcription factor 3C polypeptide 2 isoform X1
general transcription factor 3C polypeptide 2 isoform X2
general transcription factor 3C polypeptide 2 isoform X3
general transcription factor IIIC subunit 2, transcript variant X7
general transcription factor IIIC subunit 2, transcript variant X5
general transcription factor IIIC subunit 2, transcript variant X6
general transcription factor 3C polypeptide 2 isoform X5
general transcription factor 3C polypeptide 2 isoform X4
eukaryotic translation initiation factor 2B subunit delta, transcript variant X4
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 16 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 10 samples with support for all annotated introns
eukaryotic translation initiation factor 2B subunit delta, transcript variant X3
eukaryotic translation initiation factor 2B subunit delta, transcript variant X6
eukaryotic translation initiation factor 2B subunit delta, transcript variant X5
eukaryotic translation initiation factor 2B subunit delta, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 12 Proteins, and 99% coverage of the annotated genomic feature by RNAseq alignments, including 12 samples with support for all annotated introns
eukaryotic translation initiation factor 2B subunit delta, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 3 Proteins, and 99% coverage of the annotated genomic feature by RNAseq alignments, including 10 samples with support for all annotated introns
translation initiation factor eIF-2B subunit delta isoform X4
translation initiation factor eIF-2B subunit delta isoform X3
translation initiation factor eIF-2B subunit delta isoform X2
translation initiation factor eIF-2B subunit delta isoform X1
translation initiation factor eIF-2B subunit delta isoform X5
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 19 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 12 samples with support for all annotated introns
zinc finger protein 513, transcript variant X2
zinc finger protein 513, transcript variant X1
zinc finger protein 513, transcript variant X3
protein phosphatase, Mg2+/Mn2+ dependent 1G
nuclear receptor binding protein 1, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 17 Proteins, and 99% coverage of the annotated genomic feature by RNAseq alignments, including 12 samples with support for all annotated introns
nuclear receptor binding protein 1, transcript variant X2
nuclear receptor binding protein 1, transcript variant X1
nuclear receptor binding protein 1, transcript variant X4
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 99% coverage of the annotated genomic feature by RNAseq alignments, including 12 samples with support for all annotated introns
nuclear receptor-binding protein isoform X1
nuclear receptor-binding protein isoform X2
keratinocyte associated protein 3, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 12 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 6 samples with support for all annotated introns
keratinocyte associated protein 3, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 12 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 4 samples with support for all annotated introns
intraflagellar transport 172, transcript variant X2
intraflagellar transport 172, transcript variant X3
intraflagellar transport 172, transcript variant X1
intraflagellar transport protein 172 homolog isoform X2
intraflagellar transport protein 172 homolog isoform X3
intraflagellar transport protein 172 homolog isoform X1
intraflagellar transport 172, transcript variant X4
intraflagellar transport 172, transcript variant X5
fibronectin type III domain containing 4, transcript variant X2
fibronectin type III domain containing 4, transcript variant X1
fibronectin type III domain-containing protein 4 isoform X1
fibronectin type III domain-containing protein 4 isoform X2
The sequence of the model RefSeq transcript was modified relative to this genomic sequence to represent the inferred CDS: inserted 4 bases in 3 codons; Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 6 Proteins
The sequence of the model RefSeq protein was modified relative to this genomic sequence to represent the inferred CDS: inserted 4 bases in 3 codons; substituted 2 bases at 2 genomic stop codons; Derived by automated computational analysis using gene prediction method: Gnomon.
LOW QUALITY PROTEIN: glucokinase regulatory protein
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 13 Proteins
zinc finger protein 512, transcript variant X1
zinc finger protein 512, transcript variant X3
zinc finger protein 512, transcript variant X4
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 12 samples with support for all annotated introns
zinc finger protein 512, transcript variant X2
zinc finger protein 512, transcript variant X5
coiled-coil domain containing 121, transcript variant X2
coiled-coil domain containing 121, transcript variant X1
coiled-coil domain-containing protein 121 isoform X1
coiled-coil domain-containing protein 121 isoform X2
GPN-loop GTPase 1, transcript variant X1
GPN-loop GTPase 1, transcript variant X2
SPT7 like, STAGA complex subunit gamma, transcript variant X1
SPT7 like, STAGA complex subunit gamma, transcript variant X2
solute carrier family 4 member 1 adaptor protein
39S ribosomal protein L33, mitochondrial
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 87% coverage of the annotated genomic feature by RNAseq alignments
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 9 Proteins, and 62% coverage of the annotated genomic feature by RNAseq alignments
BRISC and BRCA1 A complex member 2, transcript variant X2
BRISC and BRCA1 A complex member 2, transcript variant X1
BRISC and BRCA1 A complex member 2, transcript variant X3
BRISC and BRCA1-A complex member 2 isoform X2
BRISC and BRCA1-A complex member 2 isoform X1
wiskott-Aldrich syndrome protein homolog
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 80% coverage of the annotated genomic feature by RNAseq alignments
FOS like 2, AP-1 transcription factor subunit, transcript variant X1
FOS like 2, AP-1 transcription factor subunit, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 14 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 6 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 11 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments
protein phosphatase 1 catalytic subunit beta, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 26 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 12 samples with support for all annotated introns
protein phosphatase 1 catalytic subunit beta, transcript variant X1
protein phosphatase 1 catalytic subunit beta, transcript variant X3
serine/threonine-protein phosphatase PP1-beta catalytic subunit
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 24 Proteins, and 42% coverage of the annotated genomic feature by RNAseq alignments
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 43 Proteins, and 25% coverage of the annotated genomic feature by RNAseq alignments
speedy/RINGO cell cycle regulator family member A
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 5 Proteins, and 81% coverage of the annotated genomic feature by RNAseq alignments
The sequence of the model RefSeq transcript was modified relative to this genomic sequence to represent the inferred CDS: inserted 3 bases in 2 codons; deleted 2 bases in 2 codons; Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 Proteins, and 13% coverage of the annotated genomic feature by RNAseq alignments
The sequence of the model RefSeq protein was modified relative to this genomic sequence to represent the inferred CDS: inserted 3 bases in 2 codons; deleted 2 bases in 2 codons; substituted 5 bases at 5 genomic stop codons; Derived by automated computational analysis using gene prediction method: Gnomon.
LOW QUALITY PROTEIN: tRNA (adenine(58)-N(1))-methyltransferase, mitochondrial
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 25 Proteins, and 14% coverage of the annotated genomic feature by RNAseq alignments
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 13 Proteins, and 24% coverage of the annotated genomic feature by RNAseq alignments
COORDINATES: nucleotide motif:Rfam:12.0:RF00325
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 6 Proteins, and 89% coverage of the annotated genomic feature by RNAseq alignments
TOG array regulator of axonemal microtubules 2, transcript variant X2
TOG array regulator of axonemal microtubules 2, transcript variant X1
TOG array regulator of axonemal microtubules 2, transcript variant X3
TOG array regulator of axonemal microtubules 2, transcript variant X4
TOG array regulator of axonemal microtubules 2, transcript variant X5
TOG array regulator of axonemal microtubules 2, transcript variant X6
TOG array regulator of axonemal microtubules 2, transcript variant X7
TOG array regulator of axonemal microtubules protein 2 isoform X1
TOG array regulator of axonemal microtubules protein 2 isoform X2
TOG array regulator of axonemal microtubules protein 2 isoform X3
TOG array regulator of axonemal microtubules protein 2 isoform X4
TOG array regulator of axonemal microtubules protein 2 isoform X5
TOG array regulator of axonemal microtubules protein 2 isoform X6
CAP-Gly domain containing linker protein family member 4, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 55% coverage of the annotated genomic feature by RNAseq alignments, including 2 samples with support for all annotated introns
CAP-Gly domain containing linker protein family member 4, transcript variant X4
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 11 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 6 samples with support for all annotated introns
CAP-Gly domain containing linker protein family member 4, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 18 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 12 samples with support for all annotated introns
CAP-Gly domain containing linker protein family member 4, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 18 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 8 samples with support for all annotated introns
CAP-Gly domain-containing linker protein 4 isoform X1
CAP-Gly domain-containing linker protein 4 isoform X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 30 Proteins, and 89% coverage of the annotated genomic feature by RNAseq alignments
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 6 Proteins
transforming acidic coiled-coil containing protein 1, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 13 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 4 samples with support for all annotated introns
transforming acidic coiled-coil containing protein 1, transcript variant X1
transforming acidic coiled-coil containing protein 1, transcript variant X4
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 8 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 2 samples with support for all annotated introns
transforming acidic coiled-coil containing protein 1, transcript variant X5
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 9 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 4 samples with support for all annotated introns
transforming acidic coiled-coil containing protein 1, transcript variant X10
transforming acidic coiled-coil-containing protein 1 isoform X1
transforming acidic coiled-coil-containing protein 1 isoform X3
transforming acidic coiled-coil-containing protein 1 isoform X4
transforming acidic coiled-coil containing protein 1, transcript variant X3
transforming acidic coiled-coil containing protein 1, transcript variant X14
transforming acidic coiled-coil containing protein 1, transcript variant X6
transforming acidic coiled-coil containing protein 1, transcript variant X8
transforming acidic coiled-coil containing protein 1, transcript variant X9
transforming acidic coiled-coil containing protein 1, transcript variant X11
transforming acidic coiled-coil-containing protein 1 isoform X5
transforming acidic coiled-coil-containing protein 1 isoform X7
transforming acidic coiled-coil-containing protein 1 isoform X11
transforming acidic coiled-coil containing protein 1, transcript variant X12
transforming acidic coiled-coil containing protein 1, transcript variant X13
transforming acidic coiled-coil containing protein 1, transcript variant X7
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 12 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 10 samples with support for all annotated introns
transforming acidic coiled-coil-containing protein 1 isoform X2
transforming acidic coiled-coil-containing protein 1 isoform X6
transforming acidic coiled-coil-containing protein 1 isoform X9
transforming acidic coiled-coil-containing protein 1 isoform X10
transforming acidic coiled-coil-containing protein 1 isoform X8
pleckstrin homology domain containing A2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 6 Proteins, and 98% coverage of the annotated genomic feature by RNAseq alignments
pleckstrin homology domain-containing family A member 2
uncharacterized LOC119516261, transcript variant X2
uncharacterized LOC119516261, transcript variant X1
ADAM metallopeptidase domain 9, transcript variant X2
disintegrin and metalloproteinase domain-containing protein 9 isoform X2
ADAM metallopeptidase domain 9, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 11 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 2 samples with support for all annotated introns
disintegrin and metalloproteinase domain-containing protein 9 isoform X1
ADAM metallopeptidase domain 9, transcript variant X3
disintegrin and metalloproteinase domain-containing protein 9 isoform X3
disintegrin and metalloproteinase domain-containing protein 32-like
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 Proteins, and 91% coverage of the annotated genomic feature by RNAseq alignments
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 18 Proteins
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 48 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments
A disintegrin and metallopeptidase domain 3-like
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 6 Proteins, and 88% coverage of the annotated genomic feature by RNAseq alignments
disintegrin and metalloproteinase domain-containing protein 5-like
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 7 Proteins, and 83% coverage of the annotated genomic feature by RNAseq alignments
disintegrin and metalloproteinase domain-containing protein 18-like
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 12 Proteins, and 23% coverage of the annotated genomic feature by RNAseq alignments
disintegrin and metalloproteinase domain-containing protein 2
COORDINATES: nucleotide motif:Rfam:12.0:RF00066
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 12 Proteins, and 56% coverage of the annotated genomic feature by RNAseq alignments
indoleamine 2,3-dioxygenase 2, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 4 samples with support for all annotated introns
indoleamine 2,3-dioxygenase 2, transcript variant X5
indoleamine 2,3-dioxygenase 2, transcript variant X8
indoleamine 2,3-dioxygenase 2, transcript variant X4
indoleamine 2,3-dioxygenase 2, transcript variant X1
indoleamine 2,3-dioxygenase 2, transcript variant X2
indoleamine 2,3-dioxygenase 2, transcript variant X6
indoleamine 2,3-dioxygenase 2 isoform X3
indoleamine 2,3-dioxygenase 2 isoform X1
indoleamine 2,3-dioxygenase 2 isoform X2
indoleamine 2,3-dioxygenase 2 isoform X7
indoleamine 2,3-dioxygenase 2 isoform X4
indoleamine 2,3-dioxygenase 2 isoform X5
indoleamine 2,3-dioxygenase 2, transcript variant X7
indoleamine 2,3-dioxygenase 2 isoform X6
transcriptional and immune response regulator
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 6 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments
proliferation-associated protein 2G4-like
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 15 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 20 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 8 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 23 Proteins
DNA replication complex GINS protein SLD5
glycerol-3-phosphate acyltransferase 4, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 28 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 10 samples with support for all annotated introns
glycerol-3-phosphate acyltransferase 4, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 27 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 10 samples with support for all annotated introns
glycerol-3-phosphate acyltransferase 4, transcript variant X2
glycerol-3-phosphate acyltransferase 4, transcript variant X4
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 27 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 6 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 10 Proteins, and 96% coverage of the annotated genomic feature by RNAseq alignments, including 2 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 31 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 4 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 30 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 4 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 32 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 2 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 28 Proteins, and 99% coverage of the annotated genomic feature by RNAseq alignments
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 28 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 4 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 31 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 6 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 29 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 2 samples with support for all annotated introns
lysine acetyltransferase 6A, transcript variant X2
lysine acetyltransferase 6A, transcript variant X1
histone acetyltransferase KAT6A isoform X2
histone acetyltransferase KAT6A isoform X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 24 Proteins
adaptor related protein complex 3 subunit mu 2, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 22 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 12 samples with support for all annotated introns
adaptor related protein complex 3 subunit mu 2, transcript variant X3
adaptor related protein complex 3 subunit mu 2, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 22 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 10 samples with support for all annotated introns
plasminogen activator, tissue type, transcript variant X3
plasminogen activator, tissue type, transcript variant X1
plasminogen activator, tissue type, transcript variant X2
tissue-type plasminogen activator isoform X2
tissue-type plasminogen activator isoform X1
uncharacterized LOC119516583, transcript variant X1
uncharacterized LOC119516583, transcript variant X2
inhibitor of nuclear factor kappa B kinase subunit beta, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 21 Proteins, and 99% coverage of the annotated genomic feature by RNAseq alignments, including 12 samples with support for all annotated introns
inhibitor of nuclear factor kappa B kinase subunit beta, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 21 Proteins, and 98% coverage of the annotated genomic feature by RNAseq alignments, including 12 samples with support for all annotated introns
inhibitor of nuclear factor kappa-B kinase subunit beta
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 5 Proteins, and 80% coverage of the annotated genomic feature by RNAseq alignments
dickkopf WNT signaling pathway inhibitor 4, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 6 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 2 samples with support for all annotated introns
dickkopf WNT signaling pathway inhibitor 4, transcript variant X2
voltage dependent anion channel 3, transcript variant X1
voltage dependent anion channel 3, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 39 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 12 samples with support for all annotated introns
voltage-dependent anion-selective channel protein 3 isoform X1
voltage-dependent anion-selective channel protein 3 isoform X2
solute carrier family 20 member 2, transcript variant X2
solute carrier family 20 member 2, transcript variant X4
solute carrier family 20 member 2, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 31 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 2 samples with support for all annotated introns
solute carrier family 20 member 2, transcript variant X1
solute carrier family 20 member 2, transcript variant X6
sodium-dependent phosphate transporter 2 isoform X1
sodium-dependent phosphate transporter 2 isoform X3
solute carrier family 20 member 2, transcript variant X5
sodium-dependent phosphate transporter 2 isoform X2
small integral membrane protein 19, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 15 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 10 samples with support for all annotated introns
small integral membrane protein 19, transcript variant X3
small integral membrane protein 19, transcript variant X1
uncharacterized LOC119516815, transcript variant X2
uncharacterized LOC119516815, transcript variant X1
cholinergic receptor nicotinic beta 3 subunit, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 25 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 6 samples with support for all annotated introns
phosphatidylinositol N-acetylglucosaminyltransferase subunit Y-like
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 7 Proteins
cholinergic receptor nicotinic beta 3 subunit, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 59 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 2 samples with support for all annotated introns
neuronal acetylcholine receptor subunit beta-3 isoform X1
neuronal acetylcholine receptor subunit beta-3 isoform X2
cholinergic receptor nicotinic alpha 6 subunit, transcript variant X2
cholinergic receptor nicotinic alpha 6 subunit, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 54 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 2 samples with support for all annotated introns
neuronal acetylcholine receptor subunit alpha-6 isoform X2
neuronal acetylcholine receptor subunit alpha-6 isoform X1
THAP domain containing 1, transcript variant X1
THAP domain containing 1, transcript variant X2
THAP domain-containing protein 1 isoform X2
THAP domain-containing protein 1 isoform X1
THAP domain containing 1, transcript variant X4
THAP domain containing 1, transcript variant X3
uncharacterized LOC119516545, transcript variant X3
uncharacterized LOC119516545, transcript variant X2
uncharacterized LOC119516545, transcript variant X4
uncharacterized LOC119516545, transcript variant X1
ring finger protein 170, transcript variant X1
ring finger protein 170, transcript variant X3
ring finger protein 170, transcript variant X2
hook microtubule tethering protein 3, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 15 Proteins, and 90% coverage of the annotated genomic feature by RNAseq alignments
hook microtubule tethering protein 3, transcript variant X2
protein farnesyltransferase/geranylgeranyltransferase type-1 subunit alpha
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 83% coverage of the annotated genomic feature by RNAseq alignments
protein O-mannose kinase, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 9 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 10 samples with support for all annotated introns
protein O-mannose kinase, transcript variant X2
protein O-mannose kinase, transcript variant X4
protein O-mannose kinase, transcript variant X3
protein O-mannose kinase, transcript variant X5
protein O-mannose kinase, transcript variant X6
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 6 Proteins, and 40% coverage of the annotated genomic feature by RNAseq alignments
heparan-alpha-glucosaminide N-acetyltransferase, transcript variant X3
heparan-alpha-glucosaminide N-acetyltransferase, transcript variant X1
heparan-alpha-glucosaminide N-acetyltransferase, transcript variant X2
heparan-alpha-glucosaminide N-acetyltransferase isoform X1
heparan-alpha-glucosaminide N-acetyltransferase isoform X2
heparan-alpha-glucosaminide N-acetyltransferase isoform X3
heparan-alpha-glucosaminide N-acetyltransferase, transcript variant X4
heparan-alpha-glucosaminide N-acetyltransferase isoform X4
integrator complex subunit 10, transcript variant X1
integrator complex subunit 10, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 5 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 10 samples with support for all annotated introns
integrator complex subunit 10, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 4 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 12 samples with support for all annotated introns
integrator complex subunit 10, transcript variant X4
integrator complex subunit 10, transcript variant X5
integrator complex subunit 10 isoform X4
integrator complex subunit 10 isoform X2
integrator complex subunit 10 isoform X3
integrator complex subunit 10 isoform X1
integrator complex subunit 10 isoform X5
chondroitin sulfate N-acetylgalactosaminyltransferase 1, transcript variant X5
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 23 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 2 samples with support for all annotated introns
chondroitin sulfate N-acetylgalactosaminyltransferase 1, transcript variant X6
chondroitin sulfate N-acetylgalactosaminyltransferase 1, transcript variant X3
chondroitin sulfate N-acetylgalactosaminyltransferase 1, transcript variant X4
chondroitin sulfate N-acetylgalactosaminyltransferase 1, transcript variant X1
chondroitin sulfate N-acetylgalactosaminyltransferase 1, transcript variant X2
chondroitin sulfate N-acetylgalactosaminyltransferase 1, transcript variant X7
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 23 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 6 samples with support for all annotated introns
chondroitin sulfate N-acetylgalactosaminyltransferase 1, transcript variant X8
chondroitin sulfate N-acetylgalactosaminyltransferase 1, transcript variant X11
chondroitin sulfate N-acetylgalactosaminyltransferase 1, transcript variant X10
chondroitin sulfate N-acetylgalactosaminyltransferase 1, transcript variant X9
chondroitin sulfate N-acetylgalactosaminyltransferase 1
SH2 domain containing 4A, transcript variant X2
SH2 domain containing 4A, transcript variant X6
SH2 domain containing 4A, transcript variant X5
SH2 domain containing 4A, transcript variant X4
SH2 domain containing 4A, transcript variant X3
SH2 domain containing 4A, transcript variant X1
SH2 domain containing 4A, transcript variant X7
SH2 domain-containing protein 4A isoform X5
SH2 domain-containing protein 4A isoform X4
SH2 domain-containing protein 4A isoform X3
SH2 domain-containing protein 4A isoform X2
SH2 domain-containing protein 4A isoform X1
SH2 domain-containing protein 4A isoform X6
pleckstrin and Sec7 domain containing 3, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 16 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 4 samples with support for all annotated introns
PH and SEC7 domain-containing protein 3 isoform X1
pleckstrin and Sec7 domain containing 3, transcript variant X2
pleckstrin and Sec7 domain containing 3, transcript variant X4
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 14 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 2 samples with support for all annotated introns
PH and SEC7 domain-containing protein 3 isoform X4
PH and SEC7 domain-containing protein 3 isoform X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 10 Proteins
pleckstrin and Sec7 domain containing 3, transcript variant X5
pleckstrin and Sec7 domain containing 3, transcript variant X3
PH and SEC7 domain-containing protein 3 isoform X3
PH and SEC7 domain-containing protein 3 isoform X5
pleckstrin and Sec7 domain containing 3, transcript variant X6
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 12 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 2 samples with support for all annotated introns
PH and SEC7 domain-containing protein 3 isoform X6
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 5 Proteins, and 56% coverage of the annotated genomic feature by RNAseq alignments
arylamine N-acetyltransferase 1, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 43 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 4 samples with support for all annotated introns
arylamine N-acetyltransferase 1, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 43 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 12 samples with support for all annotated introns
lipoprotein lipase, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 33 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 6 samples with support for all annotated introns
lipoprotein lipase, transcript variant X3
lipoprotein lipase, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 12 Proteins
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 14 Proteins, and 88% coverage of the annotated genomic feature by RNAseq alignments
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 29 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 12 samples with support for all annotated introns
V-type proton ATPase subunit B, brain isoform
leucine zipper tumor suppressor 1, transcript variant X1
leucine zipper tumor suppressor 1, transcript variant X2
leucine zipper putative tumor suppressor 1
GDNF family receptor alpha 2, transcript variant X2
GDNF family receptor alpha 2, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 22 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 4 samples with support for all annotated introns
docking protein 2, transcript variant X1
docking protein 2, transcript variant X2
docking protein 2, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 17 Proteins, and 80% coverage of the annotated genomic feature by RNAseq alignments
nucleophosmin/nucleoplasmin 2, transcript variant X2
nucleophosmin/nucleoplasmin 2, transcript variant X4
nucleophosmin/nucleoplasmin 2, transcript variant X5
nucleophosmin/nucleoplasmin 2, transcript variant X6
nucleophosmin/nucleoplasmin 2, transcript variant X1
nucleophosmin/nucleoplasmin 2, transcript variant X3
fibroblast growth factor 17, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 21 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 2 samples with support for all annotated introns
fibroblast growth factor 17, transcript variant X2
dematin actin binding protein, transcript variant X5
dematin actin binding protein, transcript variant X2
dematin actin binding protein, transcript variant X3
dematin actin binding protein, transcript variant X4
dematin actin binding protein, transcript variant X1
dematin actin binding protein, transcript variant X6
dematin actin binding protein, transcript variant X7
dematin actin binding protein, transcript variant X8
family with sequence similarity 160 member B2, transcript variant X1
family with sequence similarity 160 member B2, transcript variant X3
family with sequence similarity 160 member B2, transcript variant X2
family with sequence similarity 160 member B2, transcript variant X4
HR lysine demethylase and nuclear receptor corepressor, transcript variant X6
HR lysine demethylase and nuclear receptor corepressor, transcript variant X2
HR lysine demethylase and nuclear receptor corepressor, transcript variant X5
HR lysine demethylase and nuclear receptor corepressor, transcript variant X4
HR lysine demethylase and nuclear receptor corepressor, transcript variant X3
HR lysine demethylase and nuclear receptor corepressor, transcript variant X7
HR lysine demethylase and nuclear receptor corepressor, transcript variant X1
HR lysine demethylase and nuclear receptor corepressor, transcript variant X8
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 18 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 4 samples with support for all annotated introns
lysine-specific demethylase hairless isoform X6
lysine-specific demethylase hairless isoform X8
lysine-specific demethylase hairless isoform X2
lysine-specific demethylase hairless isoform X5
lysine-specific demethylase hairless isoform X4
lysine-specific demethylase hairless isoform X3
lysine-specific demethylase hairless isoform X1
lysine-specific demethylase hairless isoform X7
receptor accessory protein 4, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 27 Proteins, and 97% coverage of the annotated genomic feature by RNAseq alignments
receptor expression-enhancing protein 4 isoform X3
receptor accessory protein 4, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 40 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 12 samples with support for all annotated introns
receptor accessory protein 4, transcript variant X1
receptor expression-enhancing protein 4 isoform X2
receptor expression-enhancing protein 4 isoform X1
pulmonary surfactant-associated protein C
bone morphogenetic protein 1, transcript variant X3
bone morphogenetic protein 1, transcript variant X4
bone morphogenetic protein 1, transcript variant X1
bone morphogenetic protein 1, transcript variant X2
phytanoyl-CoA 2-hydroxylase interacting protein
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 20 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 2 samples with support for all annotated introns
phytanoyl-CoA hydroxylase-interacting protein
DNA-directed RNA polymerase III subunit RPC4
piwi like RNA-mediated gene silencing 2, transcript variant X4
piwi like RNA-mediated gene silencing 2, transcript variant X2
piwi like RNA-mediated gene silencing 2, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 21 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments
piwi like RNA-mediated gene silencing 2, transcript variant X1
piwi like RNA-mediated gene silencing 2, transcript variant X5
piwi like RNA-mediated gene silencing 2, transcript variant X6
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 14 Proteins, and 59% coverage of the annotated genomic feature by RNAseq alignments
solute carrier family 39 member 14, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 15 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 4 samples with support for all annotated introns
solute carrier family 39 member 14, transcript variant X2
solute carrier family 39 member 14, transcript variant X3
protein phosphatase 3 catalytic subunit gamma, transcript variant X1
protein phosphatase 3 catalytic subunit gamma, transcript variant X2
serine/threonine-protein phosphatase 2B catalytic subunit gamma isoform isoform X1
serine/threonine-protein phosphatase 2B catalytic subunit gamma isoform isoform X2
sorbin and SH3 domain containing 3, transcript variant X5
sorbin and SH3 domain containing 3, transcript variant X1
sorbin and SH3 domain containing 3, transcript variant X2
sorbin and SH3 domain containing 3, transcript variant X3
sorbin and SH3 domain containing 3, transcript variant X4
sorbin and SH3 domain containing 3, transcript variant X7
sorbin and SH3 domain containing 3, transcript variant X6
sorbin and SH3 domain containing 3, transcript variant X8
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 86% coverage of the annotated genomic feature by RNAseq alignments, including 8 samples with support for all annotated introns
PDZ and LIM domain protein 2-like, transcript variant X2
PDZ and LIM domain protein 2-like, transcript variant X3
PDZ and LIM domain protein 2-like, transcript variant X5
PDZ and LIM domain protein 2-like, transcript variant X4
PDZ and LIM domain protein 2-like isoform X2
PDZ and LIM domain protein 2-like, transcript variant X1
PDZ and LIM domain protein 2-like isoform X1
PDZ and LIM domain protein 2-like isoform X3
chromosome 20 C8orf58 homolog, transcript variant X1
chromosome 20 C8orf58 homolog, transcript variant X2
chromosome 20 C8orf58 homolog, transcript variant X3
uncharacterized protein C8orf58 homolog isoform X1
uncharacterized protein C8orf58 homolog isoform X2
uncharacterized protein C8orf58 homolog isoform X3
cell cycle and apoptosis regulator 2, transcript variant X1
cell cycle and apoptosis regulator 2, transcript variant X2
cell cycle and apoptosis regulator protein 2 isoform X1
cell cycle and apoptosis regulator protein 2 isoform X2
bridging integrator 3, transcript variant X4
bridging integrator 3, transcript variant X3
bridging integrator 3, transcript variant X2
bridging integrator 3, transcript variant X1
bridging integrator 3, transcript variant X5
early growth response 3, transcript variant X2
early growth response 3, transcript variant X3
early growth response 3, transcript variant X4
early growth response 3, transcript variant X1
early growth response protein 3 isoform X2
early growth response protein 3 isoform X1
early growth response protein 3 isoform X3
phosphatidylethanolamine binding protein 4, transcript variant X4
phosphatidylethanolamine binding protein 4, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 11 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 4 samples with support for all annotated introns
phosphatidylethanolamine binding protein 4, transcript variant X3
phosphatidylethanolamine binding protein 4, transcript variant X1
phosphatidylethanolamine-binding protein 4
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 19 Proteins, and 99% coverage of the annotated genomic feature by RNAseq alignments, including 12 samples with support for all annotated introns
rho-related BTB domain-containing protein 2
tumor necrosis factor receptor superfamily member 10A-like, transcript variant X4
tumor necrosis factor receptor superfamily member 10A-like isoform X4
tumor necrosis factor receptor superfamily member 10A-like, transcript variant X3
tumor necrosis factor receptor superfamily member 10A-like, transcript variant X5
tumor necrosis factor receptor superfamily member 10B-like isoform X3
tumor necrosis factor receptor superfamily member 10B-like isoform X5
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 Proteins, and 63% coverage of the annotated genomic feature by RNAseq alignments
tumor necrosis factor receptor superfamily member 10A-like, transcript variant X2
tumor necrosis factor receptor superfamily member 10A-like, transcript variant X1
tumor necrosis factor receptor superfamily member 10B-like isoform X1
tumor necrosis factor receptor superfamily member 10B-like isoform X2
tumor necrosis factor receptor superfamily member 10B-like
tumor necrosis factor receptor superfamily member 10B-like, transcript variant X2
tumor necrosis factor receptor superfamily member 10B-like, transcript variant X1
tumor necrosis factor receptor superfamily member 10B-like, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 7 Proteins, and 93% coverage of the annotated genomic feature by RNAseq alignments
R3H and coiled-coil domain-containing protein 1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 22 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 2 samples with support for all annotated introns
ectonucleoside triphosphate diphosphohydrolase 4, transcript variant X4
ectonucleoside triphosphate diphosphohydrolase 4, transcript variant X1
ectonucleoside triphosphate diphosphohydrolase 4, transcript variant X2
ectonucleoside triphosphate diphosphohydrolase 4, transcript variant X3
ectonucleoside triphosphate diphosphohydrolase 4 isoform X2
ectonucleoside triphosphate diphosphohydrolase 4 isoform X1
solute carrier family 25 member 37, transcript variant X1
solute carrier family 25 member 37, transcript variant X3
solute carrier family 25 member 37, transcript variant X2
solute carrier family 25 member 37, transcript variant X4
ADAM metallopeptidase domain 28, transcript variant X1
ADAM metallopeptidase domain 28, transcript variant X3
ADAM metallopeptidase domain 28, transcript variant X2
ADAM metallopeptidase domain 28, transcript variant X6
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 5 Proteins, and 92% coverage of the annotated genomic feature by RNAseq alignments, including 2 samples with support for all annotated introns
ADAM metallopeptidase domain 28, transcript variant X4
ADAM metallopeptidase domain 28, transcript variant X5
disintegrin and metalloproteinase domain-containing protein 28 isoform X1
disintegrin and metalloproteinase domain-containing protein 28 isoform X3
disintegrin and metalloproteinase domain-containing protein 28 isoform X2
disintegrin and metalloproteinase domain-containing protein 28 isoform X4
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 14 Proteins
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 9 Proteins, and 6% coverage of the annotated genomic feature by RNAseq alignments
disintegrin and metalloproteinase domain-containing protein 7
The sequence of the model RefSeq transcript was modified relative to this genomic sequence to represent the inferred CDS: inserted 1 base in 1 codon; Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 6 Proteins
The sequence of the model RefSeq protein was modified relative to this genomic sequence to represent the inferred CDS: inserted 1 base in 1 codon; substituted 1 base at 1 genomic stop codon; Derived by automated computational analysis using gene prediction method: Gnomon.
LOW QUALITY PROTEIN: CDKN2AIP N-terminal-like protein
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 23 Proteins, and 35% coverage of the annotated genomic feature by RNAseq alignments
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 19 Proteins
dedicator of cytokinesis 5, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 17 Proteins, and 98% coverage of the annotated genomic feature by RNAseq alignments, including 6 samples with support for all annotated introns
dedicator of cytokinesis protein 5 isoform X3
dedicator of cytokinesis 5, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 17 Proteins, and 98% coverage of the annotated genomic feature by RNAseq alignments, including 2 samples with support for all annotated introns
dedicator of cytokinesis 5, transcript variant X4
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 5 Proteins, and 98% coverage of the annotated genomic feature by RNAseq alignments, including 2 samples with support for all annotated introns
dedicator of cytokinesis 5, transcript variant X5
dedicator of cytokinesis 5, transcript variant X6
dedicator of cytokinesis 5, transcript variant X7
dedicator of cytokinesis 5, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 17 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 2 samples with support for all annotated introns
dedicator of cytokinesis protein 5 isoform X2
dedicator of cytokinesis protein 5 isoform X1
dedicator of cytokinesis protein 5 isoform X4
dedicator of cytokinesis protein 5 isoform X5
gonadotropin releasing hormone 1, transcript variant X2
gonadotropin releasing hormone 1, transcript variant X1
potassium channel tetramerization domain containing 9
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 12 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments
cell division cycle-associated protein 2
EBF transcription factor 2, transcript variant X4
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 7 Proteins, and 67% coverage of the annotated genomic feature by RNAseq alignments
EBF transcription factor 2, transcript variant X8
EBF transcription factor 2, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 36 Proteins, and 65% coverage of the annotated genomic feature by RNAseq alignments
EBF transcription factor 2, transcript variant X7
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 3 Proteins, and 58% coverage of the annotated genomic feature by RNAseq alignments
EBF transcription factor 2, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 20 Proteins, and 64% coverage of the annotated genomic feature by RNAseq alignments
EBF transcription factor 2, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 4 Proteins, and 62% coverage of the annotated genomic feature by RNAseq alignments
EBF transcription factor 2, transcript variant X6
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 6 Proteins, and 45% coverage of the annotated genomic feature by RNAseq alignments
EBF transcription factor 2, transcript variant X5
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 3 Proteins, and 45% coverage of the annotated genomic feature by RNAseq alignments
protein phosphatase 2 regulatory subunit Balpha, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 46 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 10 samples with support for all annotated introns
protein phosphatase 2 regulatory subunit Balpha, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 33 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 10 samples with support for all annotated introns
serine/threonine-protein phosphatase 2A 55 kDa regulatory subunit B alpha isoform isoform X1
serine/threonine-protein phosphatase 2A 55 kDa regulatory subunit B alpha isoform isoform X2
BCL2 interacting protein 3 like, transcript variant X1
BCL2/adenovirus E1B 19 kDa protein-interacting protein 3-like isoform X1
BCL2 interacting protein 3 like, transcript variant X2
BCL2/adenovirus E1B 19 kDa protein-interacting protein 3-like isoform X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 4 Proteins, and 98% coverage of the annotated genomic feature by RNAseq alignments, including 4 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 Proteins, and 60% coverage of the annotated genomic feature by RNAseq alignments
PNMA family member 2, transcript variant X3
PNMA family member 2, transcript variant X1
PNMA family member 2, transcript variant X2
dihydropyrimidinase like 2, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 16 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 6 samples with support for all annotated introns
dihydropyrimidinase-related protein 2 isoform X1
dihydropyrimidinase like 2, transcript variant X2
dihydropyrimidinase-related protein 2 isoform X2
adrenoceptor alpha 1A, transcript variant X4
adrenoceptor alpha 1A, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 36 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 2 samples with support for all annotated introns
adrenoceptor alpha 1A, transcript variant X2
adrenoceptor alpha 1A, transcript variant X5
adrenoceptor alpha 1A, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 36 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 4 samples with support for all annotated introns
protein tyrosine kinase 2 beta, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 64 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 12 samples with support for all annotated introns
protein tyrosine kinase 2 beta, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 52 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 12 samples with support for all annotated introns
protein-tyrosine kinase 2-beta isoform X1
protein-tyrosine kinase 2-beta isoform X2
cholinergic receptor nicotinic alpha 2 subunit, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 74 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 2 samples with support for all annotated introns
cholinergic receptor nicotinic alpha 2 subunit, transcript variant X3
cholinergic receptor nicotinic alpha 2 subunit, transcript variant X2
neuronal acetylcholine receptor subunit alpha-2 isoform X1
neuronal acetylcholine receptor subunit alpha-2 isoform X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 18 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments
L-gulonolactone oxidase, transcript variant X1
L-gulonolactone oxidase, transcript variant X2
L-gulonolactone oxidase, transcript variant X3
The sequence of the model RefSeq transcript was modified relative to this genomic sequence to represent the inferred CDS: inserted 1 base in 1 codon; Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 59% coverage of the annotated genomic feature by RNAseq alignments
scavenger receptor class A member 3, transcript variant X2
scavenger receptor class A member 3, transcript variant X1
scavenger receptor class A member 3, transcript variant X3
scavenger receptor class A member 3 isoform X1
scavenger receptor class A member 3 isoform X2
coiled-coil domain containing 25, transcript variant X1
coiled-coil domain containing 25, transcript variant X3
coiled-coil domain containing 25, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 16 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 8 samples with support for all annotated introns
coiled-coil domain-containing protein 25 isoform X3
coiled-coil domain-containing protein 25 isoform X1
coiled-coil domain-containing protein 25 isoform X2
establishment of sister chromatid cohesion N-acetyltransferase 2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 6 Proteins, and 93% coverage of the annotated genomic feature by RNAseq alignments
lymphokine-activated killer T-cell-originated protein kinase
scavenger receptor class A member 5, transcript variant X1
scavenger receptor class A member 5, transcript variant X2
scavenger receptor class A member 5, transcript variant X3
scavenger receptor class A member 5 isoform X2
scavenger receptor class A member 5 isoform X1
nuclear GTPase, germinal center associated, transcript variant X2
nuclear GTPase, germinal center associated, transcript variant X6
nuclear GTPase, germinal center associated, transcript variant X1
nuclear GTPase, germinal center associated, transcript variant X5
nuclear GTPase, germinal center associated, transcript variant X3
nuclear GTPase, germinal center associated, transcript variant X4
elongator acetyltransferase complex subunit 3, transcript variant X1
elongator acetyltransferase complex subunit 3, transcript variant X2
zinc finger protein 395, transcript variant X7
zinc finger protein 395, transcript variant X8
zinc finger protein 395, transcript variant X1
zinc finger protein 395, transcript variant X2
zinc finger protein 395, transcript variant X6
zinc finger protein 395, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments
zinc finger protein 395, transcript variant X5
zinc finger protein 395, transcript variant X4
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 9 Proteins, and 22% coverage of the annotated genomic feature by RNAseq alignments
exostosin like glycosyltransferase 3, transcript variant X5
exostosin like glycosyltransferase 3, transcript variant X3
exostosin like glycosyltransferase 3, transcript variant X2
exostosin like glycosyltransferase 3, transcript variant X1
exostosin like glycosyltransferase 3, transcript variant X4
integrator complex subunit 9, transcript variant X4
integrator complex subunit 9, transcript variant X2
integrator complex subunit 9, transcript variant X3
integrator complex subunit 9, transcript variant X1
homeobox containing 1, transcript variant X7
homeobox containing 1, transcript variant X1
homeobox containing 1, transcript variant X2
homeobox containing 1, transcript variant X3
homeobox containing 1, transcript variant X4
homeobox containing 1, transcript variant X5
homeobox containing 1, transcript variant X6
homeobox-containing protein 1 isoform X7
homeobox-containing protein 1 isoform X1
homeobox-containing protein 1 isoform X2
homeobox-containing protein 1 isoform X3
homeobox-containing protein 1 isoform X4
homeobox-containing protein 1 isoform X5
homeobox-containing protein 1 isoform X6
kinesin family member 13B, transcript variant X2
kinesin family member 13B, transcript variant X1
kinesin family member 13B, transcript variant X3
kinesin family member 13B, transcript variant X5
kinesin family member 13B, transcript variant X4
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 6 Proteins, and 84% coverage of the annotated genomic feature by RNAseq alignments
COORDINATES: nucleotide motif:Rfam:12.0:RF00004
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 8 Proteins, and 27% coverage of the annotated genomic feature by RNAseq alignments
uncharacterized LOC119516942, transcript variant X1
uncharacterized LOC119516942, transcript variant X2
peptidyl-prolyl cis-trans isomerase A-like
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 41 Proteins
methionine sulfoxide reductase A, transcript variant X1
mitochondrial peptide methionine sulfoxide reductase isoform X1
methionine sulfoxide reductase A, transcript variant X2
mitochondrial peptide methionine sulfoxide reductase isoform X2
non-histone chromosomal protein HMG-14-like
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 7 Proteins, and 39% coverage of the annotated genomic feature by RNAseq alignments
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 Proteins, and 85% coverage of the annotated genomic feature by RNAseq alignments
uncharacterized LOC119516871, transcript variant X1
uncharacterized LOC119516871, transcript variant X3
uncharacterized LOC119516871, transcript variant X2
The sequence of the model RefSeq transcript was modified relative to this genomic sequence to represent the inferred CDS: deleted 4 bases in 4 codons; Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 9 Proteins, and 6% coverage of the annotated genomic feature by RNAseq alignments
The sequence of the model RefSeq protein was modified relative to this genomic sequence to represent the inferred CDS: deleted 4 bases in 4 codons; substituted 2 bases at 2 genomic stop codons; Derived by automated computational analysis using gene prediction method: Gnomon.
LOW QUALITY PROTEIN: retinitis pigmentosa 1-like 1 protein
PIN2 (TERF1) interacting telomerase inhibitor 1
PIN2/TERF1-interacting telomerase inhibitor 1
myotubularin related protein 9, transcript variant X1
myotubularin-related protein 9 isoform X1
myotubularin related protein 9, transcript variant X2
myotubularin-related protein 9 isoform X2
L-threonine 3-dehydrogenase, mitochondrial
family with sequence similarity 167 member A, transcript variant X1
family with sequence similarity 167 member A, transcript variant X3
family with sequence similarity 167 member A, transcript variant X4
family with sequence similarity 167 member A, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 12 Proteins, and 62% coverage of the annotated genomic feature by RNAseq alignments
BLK proto-oncogene, Src family tyrosine kinase, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 78 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 2 samples with support for all annotated introns
BLK proto-oncogene, Src family tyrosine kinase, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 78 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 8 samples with support for all annotated introns
BLK proto-oncogene, Src family tyrosine kinase, transcript variant X4
BLK proto-oncogene, Src family tyrosine kinase, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 78 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 4 samples with support for all annotated introns
GATA binding protein 4, transcript variant X4
GATA binding protein 4, transcript variant X1
GATA binding protein 4, transcript variant X2
GATA binding protein 4, transcript variant X3
The sequence of the model RefSeq transcript was modified relative to this genomic sequence to represent the inferred CDS: deleted 1 base in 1 codon; Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 3 Proteins, and 98% coverage of the annotated genomic feature by RNAseq alignments, including 6 samples with support for all annotated introns
LOW QUALITY PROTEIN: endonuclease 8-like 2
farnesyl-diphosphate farnesyltransferase 1, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 31 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 12 samples with support for all annotated introns
farnesyl-diphosphate farnesyltransferase 1, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 3 Proteins, and 94% coverage of the annotated genomic feature by RNAseq alignments
sperm-associated antigen 11-like, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 6 Proteins, and 94% coverage of the annotated genomic feature by RNAseq alignments, including 2 samples with support for all annotated introns
zinc finger C2HC domain-containing protein 1A-like
uncharacterized protein LOC119516773 isoform X1
sperm-associated antigen 11-like, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 14 Proteins, and 76% coverage of the annotated genomic feature by RNAseq alignments
sperm-associated antigen 11-like isoform X2
1-acylglycerol-3-phosphate O-acyltransferase 5, transcript variant X2
1-acylglycerol-3-phosphate O-acyltransferase 5, transcript variant X1
1-acyl-sn-glycerol-3-phosphate acyltransferase epsilon isoform X2
1-acyl-sn-glycerol-3-phosphate acyltransferase epsilon isoform X1
The sequence of the model RefSeq transcript was modified relative to this genomic sequence to represent the inferred CDS: deleted 3 bases in 2 codons; Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 23 Proteins, and 99% coverage of the annotated genomic feature by RNAseq alignments, including 6 samples with support for all annotated introns
The sequence of the model RefSeq protein was modified relative to this genomic sequence to represent the inferred CDS: deleted 3 bases in 2 codons; substituted 1 base at 1 genomic stop codon; Derived by automated computational analysis using gene prediction method: Gnomon.
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 16 Proteins, and 46% coverage of the annotated genomic feature by RNAseq alignments
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 6 Proteins, and 34% coverage of the annotated genomic feature by RNAseq alignments
CUB and Sushi multiple domains 1, transcript variant X1
CUB and Sushi multiple domains 1, transcript variant X3
CUB and Sushi multiple domains 1, transcript variant X2
CUB and sushi domain-containing protein 1 isoform X1
CUB and sushi domain-containing protein 1 isoform X3
CUB and sushi domain-containing protein 1 isoform X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 37 Proteins
RAD9, HUS1, RAD1-interacting nuclear orphan protein 1-like
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 14 Proteins, and 41% coverage of the annotated genomic feature by RNAseq alignments
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 8 Proteins, and 95% coverage of the annotated genomic feature by RNAseq alignments
kelch repeat and BTB domain containing 11, transcript variant X1
kelch repeat and BTB domain containing 11, transcript variant X4
kelch repeat and BTB domain containing 11, transcript variant X3
kelch repeat and BTB domain containing 11, transcript variant X2
kelch repeat and BTB domain-containing protein 11
kelch repeat and BTB domain containing 11, transcript variant X5
Rho guanine nucleotide exchange factor 10, transcript variant X3
Rho guanine nucleotide exchange factor 10, transcript variant X2
Rho guanine nucleotide exchange factor 10, transcript variant X1
Rho guanine nucleotide exchange factor 10, transcript variant X4
rho guanine nucleotide exchange factor 10 isoform X3
rho guanine nucleotide exchange factor 10 isoform X2
rho guanine nucleotide exchange factor 10 isoform X1
rho guanine nucleotide exchange factor 10 isoform X4
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 13 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 8 samples with support for all annotated introns
DLG associated protein 2, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 22 Proteins, and 99% coverage of the annotated genomic feature by RNAseq alignments, including 2 samples with support for all annotated introns
DLG associated protein 2, transcript variant X2
disks large-associated protein 2 isoform X1
disks large-associated protein 2 isoform X2
testis development related protein, transcript variant X2
testis development related protein, transcript variant X1
testis development-related protein isoform X2
testis development-related protein isoform X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 66% coverage of the annotated genomic feature by RNAseq alignments
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 4 Proteins, and 98% coverage of the annotated genomic feature by RNAseq alignments
family with sequence similarity 110 member C
SH3 and SYLF domain containing 1, transcript variant X2
SH3 and SYLF domain containing 1, transcript variant X1
SH3 domain-containing YSC84-like protein 1
acid phosphatase 1, transcript variant X2
acid phosphatase 1, transcript variant X1
low molecular weight phosphotyrosine protein phosphatase isoform X2
low molecular weight phosphotyrosine protein phosphatase isoform X1
The sequence of the model RefSeq transcript was modified relative to this genomic sequence to represent the inferred CDS: deleted 1 base in 1 codon; Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 Proteins, and 94% coverage of the annotated genomic feature by RNAseq alignments, including 6 samples with support for all annotated introns
LOW QUALITY PROTEIN: ALK and LTK ligand 2
transmembrane protein 18, transcript variant X1
transmembrane protein 18, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 4 Proteins, and 82% coverage of the annotated genomic feature by RNAseq alignments
syntrophin gamma 2, transcript variant X1
syntrophin gamma 2, transcript variant X4
syntrophin gamma 2, transcript variant X2
syntrophin gamma 2, transcript variant X3
COORDINATES: nucleotide motif:Rfam:12.0:RF00553
thyroid peroxidase, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 19 Proteins, and 98% coverage of the annotated genomic feature by RNAseq alignments
thyroid peroxidase, transcript variant X1
thyroid peroxidase, transcript variant X2
The sequence of the model RefSeq transcript was modified relative to this genomic sequence to represent the inferred CDS: inserted 1 base in 1 codon; Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 5 Proteins, and 75% coverage of the annotated genomic feature by RNAseq alignments
LOW QUALITY PROTEIN: sex comb on midleg-like protein 2
ribonuclease H1-like, transcript variant X1
ribonuclease H1-like, transcript variant X2
myelin transcription factor 1 like, transcript variant X7
myelin transcription factor 1 like, transcript variant X3
myelin transcription factor 1 like, transcript variant X11
myelin transcription factor 1 like, transcript variant X5
myelin transcription factor 1 like, transcript variant X6
myelin transcription factor 1 like, transcript variant X4
myelin transcription factor 1 like, transcript variant X2
myelin transcription factor 1 like, transcript variant X10
myelin transcription factor 1 like, transcript variant X13
myelin transcription factor 1 like, transcript variant X1
myelin transcription factor 1 like, transcript variant X14
myelin transcription factor 1 like, transcript variant X8
myelin transcription factor 1 like, transcript variant X18
myelin transcription factor 1 like, transcript variant X16
myelin transcription factor 1 like, transcript variant X12
myelin transcription factor 1 like, transcript variant X17
myelin transcription factor 1 like, transcript variant X15
myelin transcription factor 1 like, transcript variant X19
myelin transcription factor 1 like, transcript variant X20
myelin transcription factor 1 like, transcript variant X9
myelin transcription factor 1-like protein isoform X9
myelin transcription factor 1-like protein isoform X8
myelin transcription factor 1-like protein isoform X3
myelin transcription factor 1-like protein isoform X7
myelin transcription factor 1-like protein isoform X6
myelin transcription factor 1-like protein isoform X2
myelin transcription factor 1-like protein isoform X1
myelin transcription factor 1-like protein isoform X10
myelin transcription factor 1-like protein isoform X5
myelin transcription factor 1-like protein isoform X4
uncharacterized LOC119516385, transcript variant X3
uncharacterized LOC119516385, transcript variant X1
uncharacterized LOC119516385, transcript variant X2
COORDINATES: nucleotide motif:Rfam:12.0:RF00619
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 15 Proteins, and 25% coverage of the annotated genomic feature by RNAseq alignments
COORDINATES: nucleotide motif:Rfam:12.0:RF00012
EARP complex and GARP complex interacting protein 1, transcript variant X2
EARP complex and GARP complex interacting protein 1, transcript variant X1
EARP complex and GARP complex interacting protein 1, transcript variant X3
EARP and GARP complex-interacting protein 1 isoform X2
EARP and GARP complex-interacting protein 1 isoform X1
EARP and GARP complex-interacting protein 1 isoform X3
COORDINATES: nucleotide motif:Rfam:12.0:RF00398
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 15 Proteins, and 61% coverage of the annotated genomic feature by RNAseq alignments
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 61% coverage of the annotated genomic feature by RNAseq alignments
trafficking protein particle complex subunit 12
1,2-dihydroxy-3-keto-5-methylthiopentene dioxygenase
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 43 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 10 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 44 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 12 samples with support for all annotated introns
COORDINATES: nucleotide motif:Rfam:12.0:RF00045
collectin subfamily member 11, transcript variant X3
collectin subfamily member 11, transcript variant X1
collectin subfamily member 11, transcript variant X4
collectin subfamily member 11, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 11 Proteins, and 64% coverage of the annotated genomic feature by RNAseq alignments
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 7 Proteins, and 22% coverage of the annotated genomic feature by RNAseq alignments
doublecortin domain-containing protein 2C
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 5 Proteins, and 88% coverage of the annotated genomic feature by RNAseq alignments
The sequence of the model RefSeq transcript was modified relative to this genomic sequence to represent the inferred CDS: inserted 2 bases in 1 codon; Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 9 Proteins
The sequence of the model RefSeq protein was modified relative to this genomic sequence to represent the inferred CDS: inserted 2 bases in 1 codon; substituted 1 base at 1 genomic stop codon; Derived by automated computational analysis using gene prediction method: Gnomon.
LOW QUALITY PROTEIN: translocation protein SEC62-like
small integral membrane protein 10-like protein 1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 99% coverage of the annotated genomic feature by RNAseq alignments
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 22 Proteins
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 7 Proteins, and 95% coverage of the annotated genomic feature by RNAseq alignments
uncharacterized LOC119516824, transcript variant X1
uncharacterized LOC119516824, transcript variant X2
uncharacterized LOC119516567, transcript variant X2
uncharacterized LOC119516567, transcript variant X5
uncharacterized LOC119516567, transcript variant X1
uncharacterized LOC119516567, transcript variant X3
uncharacterized LOC119516567, transcript variant X4
uncharacterized LOC119516567, transcript variant X6
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 31 Proteins, and 47% coverage of the annotated genomic feature by RNAseq alignments
The sequence of the model RefSeq protein was modified relative to this genomic sequence to represent the inferred CDS: substituted 2 bases at 2 genomic stop codons; Derived by automated computational analysis using gene prediction method: Gnomon.
LOW QUALITY PROTEIN: 60S ribosomal protein L26-like
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 14 Proteins, and 98% coverage of the annotated genomic feature by RNAseq alignments
cytidine/uridine monophosphate kinase 2, transcript variant X2
cytidine/uridine monophosphate kinase 2, transcript variant X1
UMP-CMP kinase 2, mitochondrial isoform X2
UMP-CMP kinase 2, mitochondrial isoform X1
radical S-adenosyl methionine domain containing 2
radical S-adenosyl methionine domain-containing protein 2
ring finger protein 144A, transcript variant X1
ring finger protein 144A, transcript variant X2
uncharacterized LOC119516709, transcript variant X1
uncharacterized LOC119516709, transcript variant X2
uncharacterized LOC119516266, transcript variant X1
uncharacterized LOC119516266, transcript variant X2
uncharacterized LOC119516362, transcript variant X1
uncharacterized LOC119516362, transcript variant X2
uncharacterized LOC119516752, transcript variant X3
uncharacterized LOC119516752, transcript variant X2
uncharacterized LOC119516752, transcript variant X1
inhibitor of DNA binding 2, transcript variant X2
DNA-binding protein inhibitor ID-2 isoform X2
inhibitor of DNA binding 2, transcript variant X1
DNA-binding protein inhibitor ID-2 isoform X1
kinase D interacting substrate 220, transcript variant X8
kinase D interacting substrate 220, transcript variant X6
kinase D interacting substrate 220, transcript variant X4
kinase D interacting substrate 220, transcript variant X2
kinase D interacting substrate 220, transcript variant X7
kinase D interacting substrate 220, transcript variant X5
kinase D interacting substrate 220, transcript variant X3
kinase D interacting substrate 220, transcript variant X9
kinase D interacting substrate 220, transcript variant X1
kinase D-interacting substrate of 220 kDa isoform X9
kinase D-interacting substrate of 220 kDa isoform X8
kinase D-interacting substrate of 220 kDa isoform X6
kinase D-interacting substrate of 220 kDa isoform X4
kinase D-interacting substrate of 220 kDa isoform X2
kinase D-interacting substrate of 220 kDa isoform X7
kinase D-interacting substrate of 220 kDa isoform X5
kinase D-interacting substrate of 220 kDa isoform X3
kinase D-interacting substrate of 220 kDa isoform X1
membrane bound O-acyltransferase domain containing 2, transcript variant X5
membrane bound O-acyltransferase domain containing 2, transcript variant X6
membrane bound O-acyltransferase domain containing 2, transcript variant X9
membrane bound O-acyltransferase domain containing 2, transcript variant X8
membrane bound O-acyltransferase domain containing 2, transcript variant X2
membrane bound O-acyltransferase domain containing 2, transcript variant X4
membrane bound O-acyltransferase domain containing 2, transcript variant X1
membrane bound O-acyltransferase domain containing 2, transcript variant X11
membrane bound O-acyltransferase domain containing 2, transcript variant X10
membrane bound O-acyltransferase domain containing 2, transcript variant X7
membrane bound O-acyltransferase domain containing 2, transcript variant X13
membrane bound O-acyltransferase domain containing 2, transcript variant X12
membrane bound O-acyltransferase domain containing 2, transcript variant X14
membrane bound O-acyltransferase domain containing 2, transcript variant X3
membrane bound O-acyltransferase domain containing 2, transcript variant X15
membrane bound O-acyltransferase domain containing 2, transcript variant X17
membrane bound O-acyltransferase domain containing 2, transcript variant X16
lysophospholipid acyltransferase 2 isoform X2
lysophospholipid acyltransferase 2 isoform X4
lysophospholipid acyltransferase 2 isoform X3
lysophospholipid acyltransferase 2 isoform X5
lysophospholipid acyltransferase 2 isoform X6
lysophospholipid acyltransferase 2 isoform X1
lysophospholipid acyltransferase 2 isoform X7
lysophospholipid acyltransferase 2 isoform X8
lysophospholipid acyltransferase 2 isoform X9
ArfGAP with SH3 domain, ankyrin repeat and PH domain 2, transcript variant X3
ArfGAP with SH3 domain, ankyrin repeat and PH domain 2, transcript variant X1
ArfGAP with SH3 domain, ankyrin repeat and PH domain 2, transcript variant X4
ArfGAP with SH3 domain, ankyrin repeat and PH domain 2, transcript variant X2
ArfGAP with SH3 domain, ankyrin repeat and PH domain 2, transcript variant X5
arf-GAP with SH3 domain, ANK repeat and PH domain-containing protein 2 isoform X1
arf-GAP with SH3 domain, ANK repeat and PH domain-containing protein 2 isoform X4
arf-GAP with SH3 domain, ANK repeat and PH domain-containing protein 2 isoform X2
arf-GAP with SH3 domain, ANK repeat and PH domain-containing protein 2 isoform X5
arf-GAP with SH3 domain, ANK repeat and PH domain-containing protein 2 isoform X3
integrin subunit beta 1 binding protein 1, transcript variant X2
integrin subunit beta 1 binding protein 1, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 7 Proteins, and 21% coverage of the annotated genomic feature by RNAseq alignments
cleavage and polyadenylation specific factor 3, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 6 Proteins, and 97% coverage of the annotated genomic feature by RNAseq alignments, including 10 samples with support for all annotated introns
cleavage and polyadenylation specific factor 3, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 19 Proteins, and 96% coverage of the annotated genomic feature by RNAseq alignments, including 12 samples with support for all annotated introns
cleavage and polyadenylation specificity factor subunit 3 isoform X1
cleavage and polyadenylation specificity factor subunit 3 isoform X2
cleavage and polyadenylation specific factor 3, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 4 Proteins, and 97% coverage of the annotated genomic feature by RNAseq alignments, including 6 samples with support for all annotated introns
cleavage and polyadenylation specificity factor subunit 3 isoform X3
isoamyl acetate hydrolyzing esterase 1 (putative), transcript variant X5
isoamyl acetate hydrolyzing esterase 1 (putative), transcript variant X2
isoamyl acetate hydrolyzing esterase 1 (putative), transcript variant X1
isoamyl acetate-hydrolyzing esterase 1 homolog isoform X1
isoamyl acetate-hydrolyzing esterase 1 homolog isoform X2
isoamyl acetate hydrolyzing esterase 1 (putative), transcript variant X4
isoamyl acetate hydrolyzing esterase 1 (putative), transcript variant X3
isoamyl acetate-hydrolyzing esterase 1 homolog isoform X3
ADAM metallopeptidase domain 17, transcript variant X2
ADAM metallopeptidase domain 17, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 32 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 10 samples with support for all annotated introns
ADAM metallopeptidase domain 17, transcript variant X3
disintegrin and metalloproteinase domain-containing protein 17 isoform X2
disintegrin and metalloproteinase domain-containing protein 17 isoform X1
disintegrin and metalloproteinase domain-containing protein 17 isoform X3
tyrosine 3-monooxygenase/tryptophan 5-monooxygenase activation protein theta
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 45 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 12 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 17 Proteins, and 27% coverage of the annotated genomic feature by RNAseq alignments
TATA-box binding protein associated factor, RNA polymerase I subunit B, transcript variant X1
TATA box-binding protein-associated factor RNA polymerase I subunit B isoform X1
TATA-box binding protein associated factor, RNA polymerase I subunit B, transcript variant X2
TATA-box binding protein associated factor, RNA polymerase I subunit B, transcript variant X3
TATA-box binding protein associated factor, RNA polymerase I subunit B, transcript variant X4
TATA box-binding protein-associated factor RNA polymerase I subunit B isoform X2
TATA-box binding protein associated factor, RNA polymerase I subunit B, transcript variant X5
TATA-box binding protein associated factor, RNA polymerase I subunit B, transcript variant X6
TATA box-binding protein-associated factor RNA polymerase I subunit B isoform X3
TATA-box binding protein associated factor, RNA polymerase I subunit B, transcript variant X8
TATA-box binding protein associated factor, RNA polymerase I subunit B, transcript variant X7
TATA box-binding protein-associated factor RNA polymerase I subunit B isoform X4
TATA box-binding protein-associated factor RNA polymerase I subunit B isoform X5
grainyhead like transcription factor 1, transcript variant X1
grainyhead like transcription factor 1, transcript variant X2
grainyhead-like protein 1 homolog isoform X1
grainyhead-like protein 1 homolog isoform X2
Kruppel like factor 11, transcript variant X1
Kruppel like factor 11, transcript variant X2
ribonucleotide reductase regulatory subunit M2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 14 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 8 samples with support for all annotated introns
ribonucleoside-diphosphate reductase subunit M2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 3 Proteins, and 63% coverage of the annotated genomic feature by RNAseq alignments
hippocalcin like 1, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 82 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 8 samples with support for all annotated introns
hippocalcin like 1, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 82 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 6 samples with support for all annotated introns
hippocalcin like 1, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 82 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 12 samples with support for all annotated introns
ornithine decarboxylase 1, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 28 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 12 samples with support for all annotated introns
ornithine decarboxylase 1, transcript variant X2
small nucleolar RNA SNORA42/SNORA80 family
COORDINATES: nucleotide motif:Rfam:12.0:RF00406
putative uncharacterized protein MGC34800
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 7 Proteins, and 77% coverage of the annotated genomic feature by RNAseq alignments
ATPase H+ transporting V1 subunit C2, transcript variant X1
ATPase H+ transporting V1 subunit C2, transcript variant X3
ATPase H+ transporting V1 subunit C2, transcript variant X2
ATPase H+ transporting V1 subunit C2, transcript variant X4
V-type proton ATPase subunit C 2 isoform X1
V-type proton ATPase subunit C 2 isoform X3
V-type proton ATPase subunit C 2 isoform X2
V-type proton ATPase subunit C 2 isoform X4
protein disulfide isomerase family A member 6
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 23 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 12 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 11 Proteins, and 92% coverage of the annotated genomic feature by RNAseq alignments
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 80% coverage of the annotated genomic feature by RNAseq alignments
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 82% coverage of the annotated genomic feature by RNAseq alignments
The sequence of the model RefSeq transcript was modified relative to this genomic sequence to represent the inferred CDS: inserted 2 bases in 1 codon; Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 20 Proteins, and 97% coverage of the annotated genomic feature by RNAseq alignments
The sequence of the model RefSeq protein was modified relative to this genomic sequence to represent the inferred CDS: inserted 2 bases in 1 codon; Derived by automated computational analysis using gene prediction method: Gnomon.
LOW QUALITY PROTEIN: NEDD4 family-interacting protein 2-like
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 6 Proteins, and 99% coverage of the annotated genomic feature by RNAseq alignments, including 6 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 10 Proteins, and 18% coverage of the annotated genomic feature by RNAseq alignments
zinc finger protein 596-like, transcript variant X1
zinc finger protein 596-like, transcript variant X3
zinc finger protein 596-like, transcript variant X2
zinc finger protein 596-like, transcript variant X4
zinc finger protein 596-like, transcript variant X5
zinc finger protein 705A-like isoform X3
uncharacterized protein LOC119516834 isoform X3
uncharacterized protein LOC119516834 isoform X1
potassium voltage-gated channel modifier subfamily F member 1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 8 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments
potassium voltage-gated channel subfamily F member 1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 87% coverage of the annotated genomic feature by RNAseq alignments
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 Proteins, and 27% coverage of the annotated genomic feature by RNAseq alignments
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 38% coverage of the annotated genomic feature by RNAseq alignments
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 16 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 4 Proteins, and 77% coverage of the annotated genomic feature by RNAseq alignments
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 19 Proteins, and 5% coverage of the annotated genomic feature by RNAseq alignments
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 7 Proteins, and 98% coverage of the annotated genomic feature by RNAseq alignments, including 4 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 11 Proteins, and 91% coverage of the annotated genomic feature by RNAseq alignments
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 7 Proteins, and 98% coverage of the annotated genomic feature by RNAseq alignments, including 2 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 17 Proteins, and 48% coverage of the annotated genomic feature by RNAseq alignments
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 49 Proteins
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 18 Proteins, and 35% coverage of the annotated genomic feature by RNAseq alignments